PF3D7_0717900

PF3D7_0717900 (TRX2) is a thioredoxin-like protein that functions as a non-essential but functionally important component of the PTEX (Plasmodium translocon of exported proteins) complex, where it optimizes protein export and parasite virulence (PMID:23869529). Genetic tagging and co-localization confirm TRX2 as a bona fide PTEX subunit, and its deletion in P. berghei reduces growth rates in vivo and in vitro and attenuates severe disease in a cerebral malaria model, establishing that it tunes PTEX activity without being required for survival (PMID:23869529). TRX2 is expressed across asexual blood stages, early gametocytes, mosquito stages, and liver stages, consistent with protein export operating throughout the life cycle (PMID:23869529). Biochemically, TRX2 is a poor substrate for thioredoxin reductase but can be reduced by the glutathione/glutaredoxin system in P. falciparum, indicating cross-talk between the glutathione and thioredoxin antioxidant pathways that may supply reducing equivalents where thioredoxin reductase access is limited (PMID:28479253). Beyond its role in PTEX and this redox cross-talk, no further mechanistic detail for PF3D7_0717900 has been characterized in the available corpus.

1. 2013 High

   Whether TRX2 is genuinely part of the export machinery and whether it is required for parasite viability was unknown; tagging and knockout defined it as a real PTEX subunit that optimizes but is not essential for growth and virulence.

   Evidence Epitope-tag knock-in and co-localization plus genetic knockout with in vivo/in vitro growth assays and a cerebral malaria mouse model

   PMID:23869529

   Open questions at the time

   • The specific biochemical contribution of TRX2 to translocation (e.g. substrate unfolding or disulfide handling) within PTEX is not resolved
   • No structural placement of TRX2 relative to other PTEX components is defined
   • Whether the P. berghei knockout phenotype quantitatively matches P. falciparum is not established
2. 2013 Medium

   It was unclear whether TRX2-dependent export is restricted to blood stages; expression profiling showed TRX2 is present across asexual, gametocyte, mosquito, and liver stages, consistent with export throughout the life cycle.

   Evidence Stage-specific protein detection of PTEX components across life-cycle stages

   PMID:23869529

   Open questions at the time

   • The detection method (Western vs. IFA) and quantitation are not fully specified
   • Whether TRX2 is functionally required at each of these stages was not tested
3. 2017 Medium

   How TRX2 is kept reduced was unclear given it is a poor thioredoxin reductase substrate; in vitro assays showed it can instead be reduced by the glutathione system, revealing antioxidant pathway cross-talk.

   Evidence In vitro biochemical assay measuring reduction of thioredoxins by glutathione system components in P. falciparum

   PMID:28479253

   Open questions at the time

   • Single lab and single in vitro method; not confirmed in the cellular/PTEX context
   • The physiological electron donor for TRX2 within the PTEX compartment is not established
   • The functional consequence of glutathione-mediated reduction for export activity is untested

• The precise catalytic/redox function of TRX2 during protein translocation and how its redox state is regulated in vivo remain unresolved.
• No defined in vivo substrate or redox partner of TRX2 within PTEX
• No structural or mechanistic model linking its thioredoxin-like activity to translocation
• Reduction by the glutathione system not yet demonstrated in the native compartment